GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFF) » Definitions » Beta

MedMen Enterprises (MedMen Enterprises) Beta : 1.11 (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-16), MedMen Enterprises's Beta is 1.11.


MedMen Enterprises Beta Historical Data

The historical data trend for MedMen Enterprises's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Beta Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.37 1.58

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.44 1.58 1.57 1.75 2.09

Competitive Comparison of MedMen Enterprises's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Beta distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Beta falls into.



MedMen Enterprises Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


MedMen Enterprises  (OTCPK:MMNFF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


MedMen Enterprises Beta Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines

From GuruFocus

MedMen Completes Sale of Florida Assets

By Business Wire Business Wire 08-22-2022

MedMen Extends Maturity Date of Commercial Loan Agreement

By Business Wire Business Wire 02-02-2022

MedMen Expands Brand Portfolio With Boutique Strains From Fog City Farms

By Business Wire Business Wire 01-11-2022

MedMen Prevails in Lawsuit Against Arizona-Based Whitestar Solutions

By Business Wire Business Wire 05-23-2022

MedMen Provides Annual Filing Status Report

By Business Wire 11-17-2023

MedMen Announces Cannasseur Personal Concierge Service

By Business Wire Business Wire 02-01-2022

MedMen Announces Resignation of Chief Financial Officer

By Business Wire Business Wire 06-16-2023